Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bimini Health Tech has commercialized a suite of FDA-cleared medical devices used globally in over a million procedures. Its flagship products include PureGraft® systems for fat grafting, Essence ADM™ for reconstructive surgery, Serene™ saline breast implants, and Healeon PRP®. The company’s Kerastem hair therapy showed statistically significant results in Phase II trials but is not yet available in the US. In November 2024, Bimini received new FDA clearance for its next-generation Float PRP system.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bimini Health Tech.